Fan Site: Inspired, Not Endorsed, By Rakesh Jhunjhunwala

Posts tagged ICICI Direct Research Reports

Piramal Pharma’s long term prospects are intact. Buy for target price of ₹290 (38% upside): ICICI Direct



Piramal Pharma share price target

Piramal Pharma Limited (PPL) is part of the Piramal group of companies. The company operates in 3 major segments.

Mayur Uniquoters has healthy growth prospects, healthy margin & RoIC profile (20%+) & Cash positive B/S. Buy for target price of ₹665 (25% upside): ICICI Direct



Mayur Uniquoters share price target

Mayur Uniquoters (MUL) is a leading player in technical textile domain, manufacturing synthetic leather (PVC, PU) for auto, footwear & apparels.

Somany Ceramics’ growth trajectory expected to be back by FY26. Buy for target price of ₹570 (32% upside): ICICI Direct



Somany Ceramics share price target

Somany Ceramics is the second largest tiles manufacturer in the domestic tiles market having ~80 MSM capacity along with bath fittings and sanitaryware capacity of 1.3 mn pieces and 0.78 mn pieces, respectively. Riding on real estate strong cycle, the company has guided for high single/ low double digit tiles volumes ahead in FY26

Disclaimer: This is a Fan Site in Rakesh Jhunjhunwala's name. Rakesh Jhunjhunwala is not associated with us and is in no way aware, accountable or responsible for what is stated here. Further, nothing here constiutes investment advice for you to act on. Also, we have a vested interest, and are extremely biased, in everything that we say. So Mind It!